Classen Immunotherapies, Inc. v. Biogen Idec
Classen Immunotherapies, Inc. v. Biogen Idec
304 F. App'x 866
Classen Immunotherapies, Inc. v. Biogen Idec
Opinion of the Court
In light of our decision in In re Bilski, 545 F.3d 943 (Fed.Cir. 2008) (en banc), we affirm the district court’s grant of summary judgment that these claims are invalid under 35 U.S.C. § 101. Dr. Classen’s claims are neither “tied to a particular machine or apparatus” nor do they “transforme ] a particular article into a different state or thing.” Bilski, 545 F.3d at 954. Therefore we affirm.
Case-law data current through December 31, 2025. Source: CourtListener bulk data.